Year in Review: 2021 Top CBD News from Drug Topics®

Take a look back at the top 10 CBD news articles published on Drug Topics® this year.

Did you miss the top CBD news of 2021? Catch up on the noteworthy news that you might have missed this year.

10. Selling CBD in the Pharmacy

Pharmacists interested in driving profit through CBD can start by changing their mindset.

9. CBD Legislation Remains in Limbo

Selling CBD can be profitable for pharmacies, if they follow regulatory guidelines.

8. Boosting Confidence in CBD Counseling

How to discuss CBD and answer questions frequently asked by patients

7. Survey Identifies Need for CBD Education Among Community Pharmacists

Survey results presented during the ASHP 2020 Midyear Clinical Meeting and Exhibition offered insight into community pharmacists’ knowledge and confidence of CBD products.

6. Study Explores CBD for Pain, Sleep in Hand Osteoarthritis and Psoriatic Arthritis

Investigators supplemented a slim body of existing research on CBD for pain management.

5. Develop a Plan for CBD Therapy

In a presentation from APhA2021, clinical pharmacist Danielle Fixon, PharmD, BCGP, BCPS, offers counseling tips for CBD products.

4. OTC CBD Products Currently Available in Pharmacies

Results of a study presented in a poster presentation during ASHP Midyear collected data of the available OTC CBD products being sold in Colorado pharmacies.

3. Validcare Researchers Discuss Results of CBD Liver Toxicity Study

Co-principal investigators Jeff Lombardo and Keith Aqua discuss the unique patient profiles of the study, future cohorts, and FDA's response to the findings.

2. CBD Studies on Epilepsy and Cognition Indicate No Negative Effects, Review Finds

A recent review expounded the effects that cannabidiol may be having on cognition in patients with epilepsy.

1. CBD for Women’s Health: A Profit Opportunity for Pharmacies

OTC CBD is often touted for its uses in pain management, anxiety relief, and sleep. But the popular cannabinoid has been shown to benefit women’s health, too––an opportunity that pharmacies can leverage as a cash-based revenue strategy.